- Home
- TYGO vs MIST Comparison
TYGO vs MIST Comparison
Compare TYGO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TYGO | MIST |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.0M | 138.2M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TYGO | MIST |
|---|---|---|
| Price | $1.17 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.0M |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.12 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $103,536,000.00 | N/A |
| Revenue This Year | $30.78 | $2,915.14 |
| Revenue Next Year | $21.68 | N/A |
| P/E Ratio | $123.00 | ★ N/A |
| Revenue Growth | ★ 91.68 | N/A |
| 52 Week Low | $0.93 | $1.00 |
| 52 Week High | $5.33 | $3.06 |
Technical Indicators
Market Signals| Indicator | TYGO | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 28.84 | 55.03 |
| Support Level | N/A | $1.20 |
| Resistance Level | $1.73 | $1.42 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 20.26 | 87.50 |
Price Performance
Historical ComparisonAbout TYGO Tigo Energy Inc.
Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.